CPRI Form 144: Restricted-stock vesting sale via Morgan Stanley on NYSE
Rhea-AI Filing Summary
Capri Holdings (CPRI) filed a Form 144 notifying a proposed sale of 24,217 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $478,234.89. The filing lists 119,040,814 shares outstanding and an approximate sale date of 08/11/2025.
The shares were acquired via restricted stock vesting under a registered plan on 06/15/2025 (13,236 shares) and 06/17/2025 (10,981 shares), with the stated nature of payment as services rendered. The filer represents no undisclosed material adverse information and reports no securities sold in the past three months.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale from recent restricted-stock vesting; small in absolute size relative to outstanding shares.
The Form 144 documents a planned disposition of 24,217 shares, sourced from restricted stock that vested in mid-June 2025. The transaction will be executed through Morgan Stanley Smith Barney on the NYSE and carries an indicated aggregate market value of $478,234.89. Given the filing also reports 119,040,814 shares outstanding, the sale represents a very small fraction of the total capitalization. The filing contains the standard representation that the filer is not aware of undisclosed material adverse information.
TL;DR: Disclosure aligns with Rule 144 requirements; no red flags in the notice itself.
The notice identifies the shares as resulting from restricted-stock vesting under a registered plan and states the consideration as services rendered, which is consistent with compensation-related equity distributions. The broker and approximate sale date are specified, and the filer affirms lack of undisclosed material adverse information. The document is a routine compliance filing to notify a proposed sale rather than an extraordinary corporate event.